Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Hui-dan Zhu, Ni Gu, Meng Wang, Hong-ru Kong & Meng-tao Zhou. (2015) Effects of capsicine on rat cytochrome P450 isoforms CYP1A2, CYP2C19, and CYP3A4. Drug Development and Industrial Pharmacy 41:11, pages 1824-1828.
Read now
Read now
Ying Peng, Hui Wu, Xueyuan Zhang, Fengyi Zhang, Huanhuan Qi, Yunxi Zhong, Yu Wang, Hua Sang, Guangji Wang & Jianguo Sun. (2015) A comprehensive assay for nine major cytochrome P450 enzymes activities with 16 probe reactions on human liver microsomes by a single LC/MS/MS run to support reliable in vitro inhibitory drug–drug interaction evaluation. Xenobiotica 45:11, pages 961-977.
Read now
Read now
Alan Boobis, Jean-Baptiste Watelet, Rhys Whomsley, Margherita Strolin Benedetti, Pascal Demoly & Keith Tipton. (2009) Drug interactions. Drug Metabolism Reviews 41:3, pages 486-527.
Read now
Read now
Margherita Strolin Benedetti, Rhys Whomsley, Italo Poggesi, Willi Cawello, François-Xavier Mathy, Marie-Laure Delporte, Peggy Papeleu & Jean-Baptiste Watelet. (2009) Drug metabolism and pharmacokinetics. Drug Metabolism Reviews 41:3, pages 344-390.
Read now
Read now
Articles from other publishers (29)
Dongdong Wang, Mu Li, Hanning Zhang, Congshu Feng, Lili Wu & Lesan Yan. (2023) A Novel Redox-Sensitive Drug Delivery System Based on Trimethyl-Locked Polycarbonate. Biomacromolecules 24:9, pages 4303-4315.
Crossref
Crossref
Zoi Skaperda, Fotios Tekos, Periklis Vardakas, Charitini Nepka & Demetrios Kouretas. (2021) Reconceptualization of Hormetic Responses in the Frame of Redox Toxicology. International Journal of Molecular Sciences 23:1, pages 49.
Crossref
Crossref
Lei Feng, Jing Ning, Xiangge Tian, Chao Wang, Zhenlong Yu, Xiaokui Huo, Tian Xie, Baojing Zhang, Tony D. James & Xiaochi Ma. (2021) Fluorescent probes for the detection and imaging of Cytochrome P450. Coordination Chemistry Reviews 437, pages 213740.
Crossref
Crossref
Chao-Nan Yang, Wen-Ya Peng, Lie-Chwen Lin & Tung-Hu Tsai. (2021) Protein unbound pharmacokinetics of ambroxol in the blood and brains of rats and the interaction of ambroxol with Polygala tenuifolia by multiple microdialysis. Journal of Ethnopharmacology 269, pages 113764.
Crossref
Crossref
Sirimas Sudsakorn, Praveen Bahadduri, Jennifer Fretland & Chuang Lu. (2020) 2020 FDA Drug-drug Interaction Guidance: A Comparison Analysis and Action Plan by Pharmaceutical Industrial Scientists. Current Drug Metabolism 21:6, pages 403-426.
Crossref
Crossref
Jaydeep Yadav, Erickson Paragas, Ken Korzekwa & Swati Nagar. (2020) Time-dependent enzyme inactivation: Numerical analyses of in vitro data and prediction of drug-drug interactions. Pharmacology & Therapeutics 206, pages 107449.
Crossref
Crossref
Alma MartelliValentina CitiLara TestaiSimone BrogiVincenzo Calderone. (2020) Organic Isothiocyanates as Hydrogen Sulfide Donors. Antioxidants & Redox Signaling 32:2, pages 110-144.
Crossref
Crossref
Okoh Adeyi Okoh & Philipp Klahn. (2018) Trimethyl Lock: A Multifunctional Molecular Tool for Drug Delivery, Cellular Imaging, and Stimuli-Responsive Materials. ChemBioChem 19:16, pages 1668-1694.
Crossref
Crossref
Zhao-Hui JIN, Wen QIU, Hui LIU, Xue-Hua JIANG & Ling WANG. (2018) Enhancement of oral bioavailability and immune response of Ginsenoside Rh2 by co-administration with piperine. Chinese Journal of Natural Medicines 16:2, pages 143-149.
Crossref
Crossref
Daniel D. Gallaher & Sabrina P. Trudo. 2017. Nutrition in the Prevention and Treatment of Disease. Nutrition in the Prevention and Treatment of Disease
787
807
.
Mohammad Mahdi Rezaee, Sohrab Kazemi, Mohammad Taghi Kazemi, Saeed Gharooee, Elham Yazdani, Hoda Gharooee, Mohammad Reza Shiran & Ali Akbar Moghadamnia. (2014) The effect of piperine on midazolam plasma concentration in healthy volunteers, a research on the CYP3A-involving metabolism. DARU Journal of Pharmaceutical Sciences 22:1.
Crossref
Crossref
Daniel D. Gallaher & Sabrina P. Trudo. 2013. Nutrition in the Prevention and Treatment of Disease. Nutrition in the Prevention and Treatment of Disease
697
715
.
Jianling Wang & Leslie Bell. 2012. ADME‐Enabling Technologies in Drug Design and Development. ADME‐Enabling Technologies in Drug Design and Development
129
159
.
Kazumasa Kozakai, Yasuhiro Yamada, Motoji Oshikata, Taiji Kawase, Etsuko Suzuki, Yukari Haramaki & Hideki Taniguchi. (2012) Reliable High-throughput Method for Inhibition Assay of 8 Cytochrome P450 Isoforms Using Cocktail of Probe Substrates and Stable Isotope-labeled Internal Standards. Drug Metabolism and Pharmacokinetics 27:5, pages 520-529.
Crossref
Crossref
Andrew Parkinson, Faraz Kazmi, David B. Buckley, Phyllis Yerino, Brandy L. Paris, Jeff Holsapple, Paul Toren, Steve M. Otradovec & Brian W. Ogilvie. (2011) An Evaluation of the Dilution Method for Identifying Metabolism-Dependent Inhibitors of Cytochrome P450 Enzymes. Drug Metabolism and Disposition 39:8, pages 1370-1387.
Crossref
Crossref
S. Genovese, F. Epifano, M. Curini, D. Menger, N.C.L. Zembruski & J. Weiss. (2011) In vitro effects of natural prenyloxycinnamic acids on human cytochrome P450 isozyme activity and expression. Phytomedicine 18:7, pages 586-591.
Crossref
Crossref
Hsia-lien Lin, Haoming Zhang, Christine Medower, Paul F. Hollenberg & William W. Johnson. (2011) Inactivation of Cytochrome P450 (P450) 3A4 but not P450 3A5 by OSI-930, a Thiophene-Containing Anticancer Drug. Drug Metabolism and Disposition 39:2, pages 345-350.
Crossref
Crossref
David S. Small, Nagy A. Farid, Christopher D. Payne, Christopher S. Konkoy, Joseph A. Jakubowski, Kenneth J. Winters & Daniel E. Salazar. (2010) Effect of Intrinsic and Extrinsic Factors on the Clinical Pharmacokinetics and Pharmacodynamics of Prasugrel. Clinical Pharmacokinetics 49:12, pages 777-798.
Crossref
Crossref
Katsunobu Hagihara, Miho Kazui, Atsushi Kurihara, Haruo Iwabuchi, Minoru Ishikawa, Hiroyuki Kobayashi, Naoki Tanaka, Osamu Okazaki, Nagy A. Farid & Toshihiko Ikeda. (2010) Biotransformation of Prasugrel, a Novel Thienopyridine Antiplatelet Agent, to the Pharmacologically Active Metabolite. Drug Metabolism and Disposition 38:6, pages 898-904.
Crossref
Crossref
Robert A. GoodnowJr.Jr., Alexandra Hicks, Achyutharao Sidduri, Agnieszka Kowalczyk, Romyr Dominique, Qi Qiao, Jian Ping Lou, Paul Gillespie, Nader Fotouhi, Jefferson Tilley, Noal Cohen, Satish Choudhry, Gary Cavallo, Shahid A. Tannu, Jessica D. Ventre, Danielle Lavelle, Nadine S. Tare, Hyesun Oh, Martin Lamb, Grazyna Kurylko, Rachid Hamid, Matthew B. Wright, Anjula Pamidimukkala, Thomas Egan, Ueli Gubler, Ann F. Hoffman, Xin Wei, Ying L. Li, John O’Neil, Ruben Marcano, Karen Pozzani, Tina Molinaro, Jennifer Santiago, Laura Singer, Maureen Hargaden, David Moore, A. Robert Catala, Lisa C. F. Chao, Gesine HermannRadhika Venkat, Helena Mancebo & Louis M. Renzetti. (2010)
Discovery of Novel and Potent Leukotriene B
4
Receptor Antagonists. Part 1
. Journal of Medicinal Chemistry 53:9, pages 3502-3516.
Crossref
Crossref
Michael D. Coleman. 2010. Human Drug Metabolism. Human Drug Metabolism
319
327
.
Thomas M. Polasek, Janani S. Sadagopal, David J. Elliot & John O. Miners. (2009) In vitro-in vivo extrapolation of zolpidem as a perpetrator of metabolic interactions involving CYP3A. European Journal of Clinical Pharmacology 66:3, pages 275-283.
Crossref
Crossref
Shobana Ganesan, Babu L. Tekwani, Rajnish Sahu, Lalit M. Tripathi & Larry A. Walker. (2009) Cytochrome P450-dependent toxic effects of primaquine on human erythrocytes. Toxicology and Applied Pharmacology 241:1, pages 14-22.
Crossref
Crossref
Chambers C. Hughes, Yu-Liang Yang, Wei-Ting Liu, Pieter C. Dorrestein, James J. La Clair & William Fenical. (2009) Marinopyrrole A Target Elucidation by Acyl Dye Transfer. Journal of the American Chemical Society 131:34, pages 12094-12096.
Crossref
Crossref
Scott W. Grimm, Heidi J. Einolf, Steven D. Hall, Kan He, Heng-Keang Lim, Kah-Hiing John Ling, Chuang Lu, Amin A. Nomeir, Eleanore Seibert, Konstantine W. Skordos, George R. Tonn, Robert Van Horn, Regina W. Wang, Y. Nancy Wong, Tian J. Yang & R. Scott Obach. (2009) The Conduct of in Vitro Studies to Address Time-Dependent Inhibition of Drug-Metabolizing Enzymes: A Perspective of the Pharmaceutical Research and Manufacturers of America. Drug Metabolism and Disposition 37:7, pages 1355-1370.
Crossref
Crossref
K. N. Woodward. 2009. Veterinary Pharmacovigilance. Veterinary Pharmacovigilance
423
452
.
Vincent O. Dezentjé, Henk-Jan Guchelaar, Johan W.R. Nortier, Cornelis J.H. van de Velde & Hans Gelderblom. (2009)
Clinical Implications of
CYP2D6
Genotyping in Tamoxifen Treatment for Breast Cancer
. Clinical Cancer Research 15:1, pages 15-21.
Crossref
Crossref
Dil M. Ramanathan & Richard M. Lelacheur. 2008. Mass Spectrometry in Drug Metabolism and Pharmacokinetics. Mass Spectrometry in Drug Metabolism and Pharmacokinetics
1
85
.
Melissa M. Yatzeck, Luke D. Lavis, Tzu-Yuan Chao, Sunil S. Chandran & Ronald T. Raines. (2008) A highly sensitive fluorogenic probe for cytochrome P450 activity in live cells. Bioorganic & Medicinal Chemistry Letters 18:22, pages 5864-5866.
Crossref
Crossref